Login to Your Account



Other News To Note


Friday, April 12, 2013
• Amyris Inc., of Emeryville, Calif., said its scientists published in Nature the details of a breakthrough in the field of synthetic biology that allows for the production of a key precursor to Artemisinin, the key ingredient to the preferred drug for combating malaria.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription